Protagenic Therapeutics, Inc.\new Convertible Notes Payable, Noncurrent
Protagenic Therapeutics, Inc.\new (PTIX) had Convertible Notes Payable, Noncurrent of $127.03 thousand as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Notes Payable, Noncurrent
us-gaap:ConvertibleLongTermNotesPayable · last filed 2023-03-31
- 2022-09-30: Convertible Notes Payable, Noncurrent $127.03K.
- 2022-06-30: Convertible Notes Payable, Noncurrent $103.46K.
- 2022-03-31: Convertible Notes Payable, Noncurrent $107.06K.
- 2021-12-31: Convertible Notes Payable, Noncurrent $132.28K.
| Period end | Convertible Notes Payable, Noncurrent |
|---|---|
| 2022-09-30 | $127.03K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $103.46K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $107.06K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $132.28K 10-K · filed 2023-03-31 |
| 2021-09-30 | $441.44K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $350.28K 10-Q · filed 2021-08-16 |
| 2021-03-31 | $1.13M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $1.08M 10-K · filed 2022-04-07 |
| 2020-09-30 | $1.03M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $960.71K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $433.56K 10-Q · filed 2020-06-18 |
| 2019-12-31 | $174.82K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |